Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GHB11L1 in healthy adults
NCT01078701Phase 2Completed
- Sponsor
- AVIR Green Hills Biotechnology AG
- Start
- Dec 2009
- Primary completion
- May 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GHB11L1 in influenza A/H1N1 (H1N1), sponsored by AVIR Green Hills Biotechnology AG. Started Dec 2009; status: completed.
02
Drugs
GHB11L1
03
Conditions
influenza A/H1N1 (H1N1)
Beyond the preview
Go deeper on NCT01078701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01078701.